Sequences

Pilot

US 12790368 B2: claim suggestions from a model

A sample record: a model's claim suggestions on a real published patent, from a pilot run by ConductScience on November 15, 2026. Shown read-only. A suggestion counts only once a person accepts it.

The record

Patent
US 12790368 B2Peptides capable of altering NK cell activity
Claims
16 claims, as granted, 2026-11-10.
Rules
The fixed rules found 52 features before the model was asked.
Model
One call to a language model with the claims and 25 paragraphs of the description: 87.8 seconds, 5,075 prompt tokens and 685 answer tokens.
Prompt
SHA-256 0c4ecf7b154088e23e92cb8eb3585efdecba830c1e2601f60fa3709ac0149555
Result
6 suggestions made: 1 kept for review and 5 dropped by the service's checks. Nothing was accepted or rejected.

What the model suggested

The service keeps a suggestion only when its quote is in the claim and no feature of the same kind already covers it. A kept suggestion counts only once a person accepts it.

  1. FragmentClaim 4Dropped

    “9 to 25 amino acids in length”

    • Failed The quote is not in claim 4.

    Suggestion 1 · Suggested by a language model (Pilot) · Prompt SHA-256 0c4ecf7b…

  2. IdentityClaim 4Dropped

    “at least 80% sequence identity”

    • Failed The quote is not in claim 4.

    Suggestion 2 · Suggested by a language model (Pilot) · Prompt SHA-256 0c4ecf7b…

  3. IdentityClaim 10Dropped

    “at least 80% sequence identity”

    • Failed The quote is not in claim 10.

    Suggestion 3 · Suggested by a language model (Pilot) · Prompt SHA-256 0c4ecf7b…

  4. IdentityClaim 13Dropped

    “at least 80% sequence identity”

    • Failed The quote is not in claim 13.

    Suggestion 4 · Suggested by a language model (Pilot) · Prompt SHA-256 0c4ecf7b…

  5. FragmentClaim 1Kept, to review

    “9 amino acids in length”

    Kept as F53: 9 or more amino acids.

    • Passed The quote is in claim 1.
    • Passed No feature of the same kind covers it.
    • Passed It repeats no earlier suggestion.
    • Passed Its details use only numbers from the quote.

    Suggestion 5 · Suggested by a language model (Pilot) · Prompt SHA-256 0c4ecf7b…

  6. FragmentClaim 1Dropped

    “9 amino acids in length”

    • Passed The quote is in claim 1.
    • Passed No feature of the same kind covers it.
    • Failed It repeats an earlier suggestion.

    Suggestion 6 · Suggested by a language model (Pilot) · Prompt SHA-256 0c4ecf7b…

The claims

The claims the model's suggestions name, with every feature of each: the rules' features to review, and the suggestion kept.

Claim 1

Independent2 features

1. A peptide comprising X1X2PX3RSLX4X5 (SEQ ID NO. 1), wherein each X is an amino acid, wherein P is proline, R is Arginine, S is serine, L is Leucine, X1 is Threonine or Valine, X2 is Glycine or Asparagine, X3 is Tryptophan or Glycine, X4 is Tryptophan or Phenylalanine, and X5 is Leucine or Isoleucine, and wherein the peptide is formulated in a nanoparticle and is 9 amino acids in length.

  • SEQ IDSEQ ID NO: 1To review

    “SEQ ID NO. 1”

    F1 · Characters 41 to 52 · Found by the rules

  • Fragment9 or more amino acidsSuggested (Pilot)

    “9 amino acids in length”

    F53 · Characters 369 to 391 · Suggested by the model (Pilot)

Claim 4

Independent1 feature

4. A peptide comprising X1X6PX7RX8X9FL (SEQ ID NO:4), wherein each X is an amino acid, wherein P is proline, R is Arginine, F is Phenylalanine, L is Leucine, X1 is Threonine or Valine, X6 is Alanine or Asparagine, X7 is Alanine or Glycine, X8 is Serine or Threonine, and X9 is Leucine or Methionine, and wherein the peptide is 9 amino acids in length and is linked to another molecule.

  • SEQ IDSEQ ID NO: 4To review

    “SEQ ID NO:4”

    F6 · Characters 41 to 51 · Found by the rules

Claim 10

Independent14 features

10. A method for treating a disease in a subject comprising administering to the subject a HLA-E binding peptide, wherein the peptide comprises a NKG2C+ cell activating peptide, wherein the NKG2C+ cell activating peptide comprises a sequence selected from TAPARTMFL (SEQ ID NO. 5), VNPGRSLFL (SEQ ID NO. 3), TGPWRSLWI (SEQ ID NO. 2), QMPSRSLLF (SEQ ID NO. 7), TLPKRGLFL (SEQ ID NO. 8), ILTDRSLWL (SEQ ID NO. 9), and FLPNRSLLF (SEQ ID NO. 10).

  • Sequence9-letter protein sequence in the claimTo review

    “TAPARTMFL”

    F37 · Characters 257 to 265 · Found by the rules

    Applies to SEQ ID NO: 5 (F38)

  • SEQ IDSEQ ID NO: 5To review

    “SEQ ID NO. 5”

    F38 · Characters 268 to 279 · Found by the rules

  • Sequence9-letter protein sequence in the claimTo review

    “VNPGRSLFL”

    F39 · Characters 283 to 291 · Found by the rules

    Applies to SEQ ID NO: 3 (F40)

  • SEQ IDSEQ ID NO: 3To review

    “SEQ ID NO. 3”

    F40 · Characters 294 to 305 · Found by the rules

  • Sequence9-letter protein sequence in the claimTo review

    “TGPWRSLWI”

    F41 · Characters 309 to 317 · Found by the rules

    Applies to SEQ ID NO: 2 (F42)

  • SEQ IDSEQ ID NO: 2To review

    “SEQ ID NO. 2”

    F42 · Characters 320 to 331 · Found by the rules

  • Sequence9-letter protein sequence in the claimTo review

    “QMPSRSLLF”

    F43 · Characters 335 to 343 · Found by the rules

    Applies to SEQ ID NO: 7 (F44)

  • SEQ IDSEQ ID NO: 7To review

    “SEQ ID NO. 7”

    F44 · Characters 346 to 357 · Found by the rules

  • Sequence9-letter protein sequence in the claimTo review

    “TLPKRGLFL”

    F45 · Characters 361 to 369 · Found by the rules

    Applies to SEQ ID NO: 8 (F46)

  • SEQ IDSEQ ID NO: 8To review

    “SEQ ID NO. 8”

    F46 · Characters 372 to 383 · Found by the rules

  • Sequence9-letter protein sequence in the claimTo review

    “ILTDRSLWL”

    F47 · Characters 387 to 395 · Found by the rules

    Applies to SEQ ID NO: 9 (F48)

  • SEQ IDSEQ ID NO: 9To review

    “SEQ ID NO. 9”

    F48 · Characters 398 to 409 · Found by the rules

  • Sequence9-letter protein sequence in the claimTo review

    “FLPNRSLLF”

    F49 · Characters 417 to 425 · Found by the rules

    Applies to SEQ ID NO: 10 (F50)

  • SEQ IDSEQ ID NO: 10To review

    “SEQ ID NO. 10”

    F50 · Characters 428 to 440 · Found by the rules

Claim 13

Depends on claim 100 features

13. The method of claim 10, wherein the disease is a cancer.

The rules found nothing to search in this claim.